SCHEMBL13487295

SCHEMBL13487295

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4ccc5nc(-c6ccccc6)c(-c6ccccc6)nc5c4)c4ccc(-c5ccc6ccccc6c5)cc34)cccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.35
LMNA P02545 5/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 7/20 0.35
L3MBTL1 Q9Y468 5/20 0.35
KMT2A Q03164 2/20 0.33
SRC P12931 1/20 0.33
ATM Q13315 1/20 0.33
TLR9 Q9NR96 1/20 0.33
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32
PIK3CA P42336 2/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487118 0.94 KDM4E (0.38) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487292 0.92 KDM4E (0.36) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487375 0.92 ALDH1A1 (0.36) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487185 0.91 ALDH1A1 (0.36) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487687 0.91 KDM4E (0.37) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13488063 0.91 KDM4E (0.37) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487057 0.88 ALDH1A1 (0.47) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13488062 0.86 KDM4E (0.37) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487700 0.86 KDM4E (0.37) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13487116 0.86 TDP1 (0.38) KDM4ELMNASMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KDM4E 3671/4885LMNA 3760/4885SMN1; SMN2 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.